Safety of baricitinib in vaccinated patients with severe and critical COVID-19 sub study of the randomised Bari-SolidAct trialHans‐Kittil Viermyr, Marius Trøseid, Julien Poissy et al.|EBioMedicine|2024Cited by 7
Safety of Baricitinib in Vaccinated Patients with Severe and Critical COVID-19. Sub Study of the Randomised Bari-SolidAct TrialHans‐Kittil Viermyr, Marius Trøseid, Kristian Tonby et al.|SSRN Electronic Journal|2024Cited by 1